ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,671Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 85

$1.78M Total Retail Price of All Prescriptions

Rank: 2 out of 85

272 Patients Receiving at Least One Drug in Part D
9%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 272 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

5% of this provider’s 543 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$266 was the average price of a prescription from this provider, compared to $128 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
OLANZAPINE 480 32 1 10
BENZTROPINE MESYLATE 431 29 R 2 8
INVEGA SUSTENNA 398 64 3 26
TRAZODONE HCL 306 22 4 1
ABILIFY 211 15 5 9
ZOLPIDEM TARTRATE 208 13 6 7
CYMBALTA 202 38 7 16
DIVALPROEX SODIUM 196 32 8 18
DIVALPROEX SODIUM ER 186 0 9 23
FLUOXETINE HCL 185 12 10 6
QUETIAPINE FUMARATE 163 15 11 4
INVEGA 157 0 12 36
HALOPERIDOL 155 18 13 28
PERPHENAZINE 154 51 14 33
VENLAFAXINE HCL ER 153 36 15 15
RISPERIDONE 149 0 16 2
BUPROPION XL 134 0 17 22
BUSPIRONE HCL 125 20 18 21
BUPROPION HCL SR 125 0 18 13
LAMOTRIGINE 116 0 20 11
CITALOPRAM HBR 109 18 21 3
LITHIUM CARBONATE 99 0 22 14
HALOPERIDOL DECANOATE 91 11 23 49
GABAPENTIN 89 0 24 19
CHLORPROMAZINE HCL 86 0 25 40
FLUPHENAZINE HCL 86 0 25 43
SEROQUEL 84 0 27 27
MIRTAZAPINE 83 0 28 12
VIIBRYD 74 0 29 71
TOPIRAMATE 72 0 30 25
SERTRALINE HCL 66 12 31 5
CLOZAPINE 66 0 31 17
AMITRIPTYLINE HCL 62 0 R 33 32
PAROXETINE HCL 61 0 34 20
OXCARBAZEPINE 61 0 34 42
FAZACLO 59 0 36 80
LATUDA 59 0 36 38
RISPERDAL CONSTA 56 0 38 31
ZYPREXA RELPREVV 51 0 39 90
FLUPHENAZINE DECANOATE 50 0 40 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.